BETA
Beta Drugs Limited
NSELast Traded Price
₹2195.1
0.9 (0.04%)
Open
₹2194.2
High
₹2253
Low
₹2166.2
Prev Close
₹2194.2
Industry
Pharmaceuticals
Market Cap
2433.46 Cr
Filing History
Recent corporate announcements and filings for BETA
Ownership
Positive
2026-08-18 12:09
- Board approved the allotment of 35,383 Bonus Equity Shares of face value INR 10 each to holders of Compulsorily Convertible Debentures (CCDs) upon their conversion into Equity Shares. - Decision made at the Board meeting on August 18, 2026.
Financials
Positive
2026-07-23 17:56
- Consolidated Revenue ₹125.55 Cr vs ₹100.21 Cr (▲25.28% YoY)
- EBITDA ₹27.37 Cr vs ₹19.71 Cr (▲38.86% YoY)
- PAT ₹16.49 Cr vs ₹11.70 Cr (▲40.94% YoY)
- EBITDA Margin 21.80% vs 19.67% (▲213 bps)
Financials
Positive
2026-07-20 09:01
- Consolidated Revenue ₹125.55Cr vs ₹100.21Cr (▲25.3% YoY)
- EBITDA (excl. other income) ₹27.37Cr vs ₹19.70Cr (▲38.9% YoY)
- PAT ₹16.49Cr vs ₹11.70Cr (▲40.9% YoY)
- EBITDA Margin 21.80% vs 19.66% (▲214bps)
Routine
Neutral
2026-06-30 13:00
- Trading window closed for Directors, Officers, Designated Employees, and their immediate relatives.
- Closure effective from July 1, 2026.
- Reopens 48 hours after the declaration of Un-Audited Financial Results for Q1 ended June 30, 2026.